Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997;337:1350–8. , , , et al.
A study of anal intraepithelial neoplasia in HIV positive homosexual men. Sex Transm Infect 1999;75:172–7. , , , et al.
Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis 1998;177:361–7. , , , et al.
High prevalence of human papillomavirus infection in the anus, penis and mouth in HIV-positive men. AIDS 2006;20:1201–4. , , , et al.
Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG cohort study. J Infect Dis 2009;199:965–73. , , , et al.
Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS 2005;19:1407–14. , , , et al.
High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy. Sex Transm Dis 2004;31:96–9. , , , et al.
Condylomata, cytological abnormalities and human papillomavirus infection in the anal canal in HIV-infected men. HIV Med 2012;13:549–57. , , , et al.
High-risk HPV (HR-HPV) prevalence by HIV-1 status in Spanish men who have sex with men (MSM) in an out patient sexually transmitted diseases clinic and in a prospective cohort of HIV-positive MSM belonging to Spanish Multicenter Cohort (CoRIS), Presented at the 17th Conference on Retroviruses and Opportunistic Infections (CROI), San Francisco, CA, February 16–19, 2010. , , , et al.
HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome? J Acquir Immune Defic Syndr 2004;37:1563–5. , , , et al.
Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr 2008;48:491–9. , , , et al.
Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992–2003. Ann Intern Med 2008;148:728–36. , , , et al.
Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy. AIDS 2008;22:1203–11. , , , et al.
A population-based analysis of temporal trends in the incidence of squamous anal canal cancer in relation to the HIV epidemic. J Acquir Immune Defic Syndr 2005;40:451–5. , , , et al.
Increased incidence of squamous cell anal cancer among men with AIDS in the era of highly active antiretroviral therapy. Sex Transm Dis 2005;32:314–20. , , , et al.
Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 2000;92:1500–10. , , .
The spectrum of malignancies in HIV-infected patients in 2006 in France: the ONCOVIH study. Int J Cancer 2011;129:467–75. , , , et al.
High incidence of anal cancer among AIDS patients. The AIDS/Cancer Working Group. Lancet 1994;343:636–9. , , , et al.
Spectrum of human papillomavirus-related dysplasia and carcinoma of the anus in HIV-infected patients. AIDS Read 2005;15:79–82, 85–6, 88, 91. , , .
Anal cancers among HIV-infected persons: HAART is not slowing rising incidence. AIDS 2010;24:535–43. , , , et al.
Cancer risk in people infected with human immunodeficiency virus in the United States. Int J Cancer 2008;123:187–94. , , , et al.
The impact of highly active antiretroviral therapy on non-AIDS-defining cancers among adults with AIDS. Am J Epidemiol 2007;165:1143–53. , , , et al.
Cancer incidence in the multicenter aids cohort study before and during the HAART era: 1984 to 2007. Cancer 2010;116:5507–16. , , , et al.
Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapy. AIDS 2009;23:2183–90. , , , et al.
Cumulative incidence of cancer among individuals with acquired immunodeficiency syndrome in the United States. Cancer 2011;117:1089–96. , , .
Association of cancer with AIDS-related immunosuppression in adults. JAMA 2001;285:1736–45. , , , et al.
Anal human papillomavirus infection and anal cancer in HIV-positive individuals: an emerging problem. AIDS 1994;8:283–95. .
Anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual and bisexual men: prevalence and risk factors. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:320–6. , , , et al.
Comparison of patient- and clinician-collected anal cytology samples to screen for human papillomavirus-associated anal intraepithelial neoplasia in men who have sex with men. Ann Intern Med 2008;149:300–6. , , , et al.
Factors associated with prevalent abnormal anal cytology in a large cohort of HIV-infected adults in the United States. J Infect Dis 2010;202:1567–76. , , , et al.
Human papillomavirus, anal squamous intraepithelial lesions, and human immunodeficiency virus in a cohort of gay men. J Infect Dis 1998;178:45–52. , , , et al.
Anal squamous intraepithelial lesions among HIV positive and HIV negative men who have sex with men in Thailand. Sex Transm Infect 2009;85:503–7. , , , et al.
Anal cytological abnormalities and anal HPV infection in men with Centers for Disease Control group IV HIV disease. Genitourin Med 1997;73:174–80. , , , et al.
Anal intraepithelial neoplasia in heterosexual and homosexual HIV-positive men with access to antiretroviral therapy. J Infect Dis 2004;190:1685–91. , , , et al.
HAART and progression to high-grade anal intraepithelial neoplasia in men who have sex with men and are infected with HIV. Clin Infect Dis 2011;52:1174–81. , , , et al.
The role of cytology (Pap tests) and human papillomavirus testing in anal cancer screening. AIDS 2010;24:1307–13. , , , et al.
Prevalence of anal intraepithelial neoplasia defined by anal cytology screening and high-resolution anoscopy in a primary care population of HIV-infected men and women. Dis Colon Rectum 2011;54:433–41. , , , et al.
Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 2009;124:1626–36. , , , et al.
Screening for HIV-associated anal cancer: correlation of HPV genotypes, p16, and E6 transcripts with anal pathology. Cancer Epidemiol Biomarkers Prev 2009;18:1986–92. , , , et al.
Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:314–19. , , , et al.
High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men. AIDS 1998;12:495–503. , , , et al.
HIV-associated anal dysplasia: experience from a multiethnic-HIV clinic in Hawaii. J Health Care Poor Underserved 2011;22:16–22. , , , et al.
Routine anal cytology screening for anal squamous intraepithelial lesions in an urban HIV clinic. Sex Transm Dis 2008;35:197–202. , , , et al.
on behalf of CoRIS-HPV Study Group. What drives the number of high risk human papillomavirus types in the anal canal in HIV-positive men who have sex with men? J Infect Dis, in press. , , , et al.;
Age-specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study. J Infect Dis 2004;190:2070–6. , , , et al.
Age-specific prevalence of and risk factors for anal human papillomavirus (HPV) among men who have sex with women and men who have sex with men: the HPV in men (HIM) study. J Infect Dis 2011;203:49–57. , , , et al.
Anal human papillomavirus genotype diversity and co-infection in a community-based sample of homosexual men. Sex Transm Infect 2009;85:330–5. , , , et al.
Risk factors for anal human papillomavirus infection and anal cytologic abnormalities in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr 1994;7:599–606. , , .
Relationship between human papillomavirus infection and tumours of anogenital sites other than the cervix. IARC Sci Publ 1992:223–41. , .
Interrater agreement of anal cytology. Cancer Cytopathol 2013;121:72–8. , , , et al.